UPA LABS | UPRET 60 Retatrutide 60mg (Not Mixed) | Compound Peptide Vial
High-Strength Triple Receptor Metabolic Research Compound (Unmixed Vial)
Retatrutide is an investigational peptide studied for its multi-receptor activity across GLP-1, GIP, and glucagon pathways.
It is widely referenced in scientific research exploring complex metabolic signalling, energy regulation mechanisms, and multi-pathway peptide interactions within controlled laboratory environments.
Developed as a 60mg unmixed vial, this formulation is designed for advanced laboratory preparation and research applications where higher-strength compound handling and controlled formulation studies are required.
Key Benefits – UPA Labs UPRET 60mg Retatrutide Compound Peptide Vial (Not Mixed)
• Triple receptor research compound targeting GLP-1, GIP, and glucagon pathways
• Investigated in metabolic signalling and endocrine research models
• Of interest in multi-pathway peptide interaction studies
• 60mg unmixed vial format for laboratory preparation use
• Suitable for advanced controlled research handling and formulation studies
• High-strength investigational formulation from UPA Labs
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
